Feasibility study of postoperative adjuvant therapy using S-1 after curative esophagectomy for esophageal cancer
- Conditions
- Esophageal cancer
- Registration Number
- JPRN-jRCT1060220042
- Lead Sponsor
- Hirahara Noriyuki
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 45
1) Histologically confirmed esophageal squamous cell carcinoma or adenocarcinoma.
2) Postoperative adjuvant chemotherap using S-a was performed.
3) Curative gastrectomy was performed.
4) Performance status of 0-1 on the Eastern Cooperative Oncology Group classification
5) No prior chemotherapy, radiation, endcrine, molecular targeted therapy within 5 years including treatment for other cancers,
6) Sufficient oral intake.
(1)Double cancer
(2)Heart failure, hepatitis, renal dysfunction
(3)Severe infection
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method